FlyPark: A High-Throughput Drosophila Platform for Parkinson's Disease Drug Screening
Project Overview
One Liner: An improved method to scale reflex observation in Drosophila
Company: Drexel University
Parkinsons Disease (PD) is the second most common neurodegenerative disease worldwide, and symptom-mitigating care imposes an economic burden of more than $80 billion in the United States. Despite widespread public recognition, there is still no cure for PD. Drug screening is a critical part of PD research, allowing biological drug responses to be studied for safety and efficacy before human trials are considered. Drosophila (Fruit flies) are commonly used in PD research for their ease of care and genetic similarities to human PD. FlyPark is an automated Drosophila observation platform designed to improve throughput compared to traditional methods that involve manual tethering, which can be a lengthy and difficult process. The handling and observation of flies will be automated to standardize data collection and improve reproducibility of Drosophila-based drug studies.
No video available.
Screenshots
0 image(s)No screenshots uploaded yet.